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Summary. — Phase-based approaches can revolutionize X-ray imaging and remove
its main limitation: poor image contrast arising from low attenuation diﬀerences.
They exploit the unit decrement of the real part of the refractive index, typically
1000 times larger than the imaginary part driving attenuation. This increases the
contrast of all details, and enables the detection of features classically considered
“X-ray invisible”. Following pioneering experiments dating back to the mid-sixties,
X-ray phase contrast imaging “exploded” in the mid-nineties, when third generation
synchrotron sources became more widely available. Applications were proposed in
ﬁelds as diverse as material science, palaeontology, biology, food science, cultural
heritage preservation, and many others. Among these applications, medicine has
been constantly considered the most important; among medical applications, mam-
mography is arguably the one that attracted most attention. Applications to mam-
mography were pioneered by the SYRMEP (SYnchrotron Radiation for MEdical
Physics) group in Trieste, which was already active in the area through a combi-
nation of innovative ways to do imaging at synchrotrons and development of novel
X-ray detectors. This pioneering phase led to the only clinical experience of phase
contrast mammography on human patients, and spawned a number of ideas as to
how these advances could be translated into clinical practice.
PACS 87.59.-e – X-ray imaging.
PACS 41.60.Ap – Synchrotron radiation.
PACS 87.59.E- – Mammography.
PACS 42.25.Gy – Edge and boundary eﬀects; reﬂection and refraction.
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1. – X-ray phase contrast imaging vs. conventional X-ray imaging
The idea of using X-rays to produce images of the inner parts of the body dates
back to the discovery of X-rays themselves: Ro¨ntgen’s radiograph of his wife’s hand
was taken only a month and a half after he discovered X-rays [1, 2]. To some extent
surprisingly, despite very signiﬁcant innovations like computed tomography [3, 4] and
the advent of digital detectors [5], the physical principle exploited to generate image
contrast has remained the same since then. This principle is the diﬀerence in the X-ray
attenuation coeﬃcients of diﬀerent materials (ﬁg. 1).
This is a simple, straightforward and very eﬀective way to generate image contrast
with X-rays. Calculating this contrast is also rather simple. If one deﬁnes the attenuation
contrast as
Catt =
I1 − I2
I1
,(1)
where I2 is the X-ray intensity transmitted in the shadow of the detail and I1 the intensity
transmitted immediately outside it, then using Beer-Lambert’s law [6] one obtains
I1 = I0 exp(−μ1t1); I2 = I0 exp[−μ1(t1 − t2)] exp(−μ2t2),(2)
where I0 is the X-ray intensity incident on the object, μ2 the attenuation coeﬃcient of
the detail, μ1 the attenuation coeﬃcient of the background, t2 and t1 the thicknesses of
detail and background, respectively. By inserting the results of eq. (1) into the deﬁnition
of Catt, one obtains [7]
Catt = 1− exp[(μ1 − μ2)t2],(3)
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Fig. 1. – Contrast formation in conventional X-ray imaging.
from which it appears immediately obvious that the conventional attenuation contrast
tends to vanish if a) μ1 ∼ μ2, i.e. the diﬀerence between the attenuation coeﬃcients of
detail and background is small, or if b) t2 ∼ 0, i.e. the detail is thin.
Being based on a diﬀerent physical principle, X-Ray Phase Contrast imaging (XPCi)
can help in both the above cases. The best way to understand the underpinning physical
diﬀerence is to refer to the complex refractive index n:
n = 1− δ + iβ,(4)
where i is the imaginary unit. The imaginary term β is linked to the attenuation prop-
erties of a given material, and in fact, within reasonable approximation one can write [8]
μ =
4πβ
λ
,(5)
where λ is the X-ray wavelength. On the other hand, δ is responsible for the phase shift
Φ suﬀered by the X-ray wave ﬁeld when it transverses a given thickness of material
Φ(x, y) =
2π
λ
∫
object
δ(x, y, z)dz,(6)
where z is the propagation direction of the X-rays, and the integral is extended over the
thickness of the imaged object along z. δ is directly linked to the electron density ρe of
a given material, and to good approximation (e.g. away from absorption edges) one can
write
δ =
reρeλ
2
2π
,(7)
where re is the classical electron radius. Both δ and β are eﬀectively related to the
real and imaginary part of the atomic scattering factors, and more detail on this can
be found in [9]. They have very diﬀerent dependences upon X-ray energy (ﬁg. 2), and
the noteworthy aspect here is that, for most materials and over the range of energies
commonly employed in X-ray imaging, δ is much larger than β —typically up to 1000
times larger. This means that, if properly exploited, phase eﬀects can lead to a dramatic
increase in image contrast. However, as will be clearer from the following, this contrast
manifests itself in a rather diﬀerent form compared to Catt. Typically, in XPCi single
(see sects. 2.2, 2.4 and 2.5) or double (sect. 2.3) pairs of dark/bright fringes underline
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Fig. 2. – Values of δ and β for PMMA (often used as a tissue substitute in phantoms) between
10 and 30 keV. The semi-logarithmic graph shows both the large diﬀerence between δ and β
values, and their diﬀerent dependence on X-ray energy.
the presence of details in an image. As a consequence, the (phase) contrast of a given
detail is often re-deﬁned as
Cphase =
Imax − Imin
Ibackground
,(8)
where Imax and Imin are the maximum and minimum intensities observed on the bright
and dark fringes respectively, while Ibackground is the intensity observed away from the
detail. Only when crystal interferometers (see sect. 2.1) are used, which are directly
sensitive to phase rather than to its ﬁrst or second derivative like the methods described
in sects. 2.2-2.5, deﬁnitions of contrast more similar to the standard “area” contrast
concept underpinned by eq. (1) can be adopted. Alternatively, these ﬁrst and second
derivatives of the phase term must be integrated to yield a “pure phase” image, which
normally comes at the cost of signiﬁcant image artefacts. These technical aspects will be
discussed in more detail in the following sections.
Quite obviously, changes in Φ have been present since the origins of X-ray imaging: the
fact that they had never been spotted before dedicated experiments were set up indicates
that normally they do not manifest themselves. In fact, since X-ray detectors are sensitive
to changes in X-ray intensity, strategies must be devised that enable converting changes
in Φ into intensity diﬀerences on the detector. Broadly speaking, two main principles are
exploited: the detection of interference patterns [10-12], or the use of X-ray refraction [13-
15].
Figure 3 shows eﬀectively the same situation as shown in ﬁg. 1, where however the
incident X-rays are represented in terms of wave fronts, and the detail and its background
have been characterized by means of their δ instead of their μ (i.e., β) values. A detail
causing an advanced wave front is represented, which is the situation encountered when
δ2 > δ1; if δ1 > δ2, the wave front behind the detail would be delayed. It should be
noted, however, that the case of advanced wave front is always encountered for isolated
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Fig. 3. – Interpretation of X-ray interaction with a sample consisting of a detail immersed in a
uniform background in terms of wave eﬀects.
objects (i.e. ideally surrounded by vacuum, in practice by air) since, as made clear by
eq. (4) jointly with the fact that for X-rays δ is positive (ﬁg. 2), for X-rays the real part
of the refractive index is negative (N.B.: this does not of course violate relativity, as the
group velocity still does not exceed the speed of light [16]).
Regardless of whether we are dealing with an advanced or delayed wave front, this
distortion can be used to generate detectable intensity changes. These are obtained ei-
ther by letting the wave propagate though a suﬃcient distance so that perturbed and
unperturbed components of the wave front interfere thus generating a detectable pat-
tern [11, 12], or by re-combining the perturbed wave with its unperturbed version in an
interferometer [10]. Details on both these approaches are given in the next section.
An alternative approach consists in picking up faint changes in the X-ray propagation
direction. This requires remembering that, locally, the direction of the X-ray is orthog-
onal to the wave front. As a consequence, a local distortion in the wave front translates
directly into a small change in the propagation direction. This is schematically repre-
sented in ﬁg. 4.
This is eﬀectively X-ray refraction, analogous to refraction in the visible light regime,
only involving much smaller angles (typically of the order of the microradian: the angle
under which 1mm is seen from a distance of 1 km). This deviation depends on the local
variation in the phase shift, and is maximal where the phase changes most abruptly. In
fact, the refraction angle α can be calculated by taking the ﬁrst derivative of the phase
shift Φ (given by eq. (6))
α ∼= λ
2π
∇x,yΦ,(9)
where∇x,y indicates the two-dimensional gradient (Φ does not depend on z, as made clear
by the integral in eq. (6)), with the two partial derivatives yielding the two components
of the refraction angle.
This is a simpliﬁed description, that corresponds to reverting from a wave optics to
an (approximated) ray-optics representation of the phenomenon. However, as will be
discussed in more detail below, this is an eﬀective and reliable description, which holds
under a wide and varied range of circumstances [17,18].
While this introductory section outlined the concepts of attenuation and phase-based
contrast, and discussed the general principles on the basis of which phase changes mecha-
nisms can be exploited to generate image contrast, the next chapter will examine in more
detail the speciﬁc methods that have been developed so far to achieve this in practice.
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Fig. 4. – How, in the ray-tracing representation, object-induced wave front distortions translate
into local changes in the X-ray propagation direction (for ease of visualization, the deviation
has been highly exaggerated in the ﬁgure).
Section 3 will then discuss the importance of mammography as a “key” application of
XPCi, and review the important results obtained in Trieste, in what is to date the only
in vivo application of XPCi to human patients. Finally, sect. 4 will look into possible
options to translate the successful results obtained in Trieste more broadly into clinical
settings, which would require eliminating the need for synchrotron sources.
2. – X-ray phase contrast imaging methods
This section will follow an historical perspective, meaning for example that, albeit
the “free-space propagation” or “in-line holography” approach hinted at immediately
below ﬁg. 3 is eﬀectively simpler, the crystal-based X-ray interferometer will be discussed
ﬁrst, as it was the ﬁrst XPCi method to be developed and used. For the same reason,
refraction-based methods like analyser-based imaging will also be discussed before free-
space propagation. The next ﬁve sub-sections will discuss the main ﬁve XPCi methods
following the order with which they were introduced.
2.1. Bonse-Hart interferometry . – The ﬁrst phase contrast images were obtained mak-
ing use of the crystal interferometer developed in 1965 by Bonse and Hart [10,19].
Figure 5 shows a top view of the instrument. All crystal blades operate in Laue
mode: the ﬁrst one (also called “beam splitter” S) splits the incoming beam in two;
the second one (“mirror” M) sends (parts of the) separated beams again towards the
same direction. The two beams therefore meet again in a position symmetrical to S
with respect to M : here, an interference pattern is formed. However, the fringes in this
pattern have the same spacing as the Bragg planes in the crystal, and are therefore very
diﬃcult to detect directly: the problem is solved by the introduction of the 3rd crystal
blade (the “analyser” A). An additional arrangement often used to simplify the imaging
process is the introduction of a phase shifter (e.g. a wedge-shaped object) in one of the
two branches of the interferometer, in a method called fringe scanning [20]. The phase
shifter creates regularly spaced (“carrier”) fringes, and the displacement of these fringes
caused by the introduction of a sample can be related back to the phase shift caused by
the sample itself.
An important thing to notice is that all three blades S, M and A are attached to a com-
mon base, not visible in the top view schematic of ﬁg. 5. In fact, crystal interferometers
are normally obtained by channel-cutting a single crystal block, which guarantees that
the distances between the blades is correct to within the required (subatomic) distance.
Following an important attempt by Ando and co-workers [21], and although Hart did
some signiﬁcant imaging experiments himself [22], the Bonse-Hart interferometer was
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Fig. 5. – Schematic representation of the Bonse-Hart interferometer.
widely used in the mid-nineties by Momose and his group for medical imaging exper-
iments [23-27]. 1995 is the year in which XPCi “exploded”: several papers exploiting
diﬀerent approaches were published by various groups (see below), in a sudden signiﬁcant
increase of interest (partially due to 3rd generation synchrotron machines becoming more
widely available) that lasts to these days. Among these, Momose’s 1995 NIM A [23], with
its Jan. 1 publication date, is incontestably the ﬁrst, and presents preliminary results
achieved in 1994 and before (the paper was submitted on March 1, 1994). In the fol-
lowing years, Momose repeatedly showed increased tumour detectability [24], which was
also extended to CT approaches [25], and started looking at diﬀerent tissues such as
brain [26] and blood [27].
Although a direct comparison is made diﬃcult by its direct dependence on Φ (while
other methods are sensitive to either the ﬁrst or second derivative of Φ), Bonse/Hart
interferometry tends to be considered the most sensitive XPCi method [28], and this is
reﬂected directly by the stunning results obtained on soft biological tissues by Momose
and other researchers. However, the method is not of straightforward use, is highly sen-
sitive to vibrations and alignment errors, and most of all oﬀers a limited ﬁeld of view due
to the monolithic nature of the crystal the interferometer is obtained from. For these
reasons, its use has decreased since the mid-90 s, and, to the best of our knowledge, no
attempt has been made at translations for “mainstream” use with conventional sources.
However, creative new ﬂexible and “multi-modal” implementations, often straddling crys-
tal interferometry and the analyser-based methods described in the next section, have
been proposed by Ando and his group [29-31].
2.2. Analyzer-based imaging . – A signiﬁcant simpliﬁcation of the Bonse/Hart interfer-
ometer comes from the use of a single crystal as an “analyser” of sample-induced changes
in the X-ray direction, hence the name “analyser-based imaging” (ABI). Although only
one crystal (sometimes two, in a “double-bounce” conﬁguration) is used as post-sample
beam analyser, more crystals are needed for beam preparation upstream of the sample.
In synchrotron experiments, these are typically provided by the beamline monochroma-
tor (see ﬁg. 6), while more crystals have to be added to the set-up if a conventional
source is used (see e.g. ﬁg. 1 in ref. [13]; this is more clearly appreciable in the related
patent [32], which also presents some alternative designs).
A possible embodiment at a synchrotron beamline is shown in ﬁg. 6. Note that the
beam cross-section is typically small (a few mm) at least in one direction —normally
the vertical one— while it can be suﬃciently large as to cover the entire sample in the
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Fig. 6. – Analyzer-based imaging in its synchrotron implementation. The X-ray beam, coming
from the left-hand side, is monochromatized by a double-bounce crystal, traverses the sample,
is further reﬂected by the “analyser” crystal and eventually reaches the detector.
horizontal one (i.e. the direction entering the plane of the drawing in ﬁg. 6). As a
consequence, two-dimensional images are obtained by scanning the sample through this
“laminar” beam. This could be coupled either with a linear detector (which is read out
at every sample position, the stored image rows then being recombined to form the full
2D image) or, if an area detector is used, this also has to be scanned through the beam.
If a single analyser crystal is used as in ﬁg. 6, not only must the detector plane have
an inclination which depends on the crystal’s Bragg angle (and therefore on the beam
energy): sample and detector must also be scanned in opposite directions, to compensate
for the inversion caused by the crystal’s reﬂection (see how the bottom part of the beam
becomes the top part after the analyser crystal, and vice versa). Both detector inclination
and need to scan in opposite directions are avoided if a double-bounce analyser crystal
is used.
In both cases, the analyser crystal’s narrow reﬂectivity curve [33] is exploited to
generate image contrast arising from refraction, as schematized in ﬁg. 7. Eﬀectively,
rather than the intrinsic reﬂectivity curve, the “rocking” curve —i.e. the variation in
intensity observed while rotating the crystal around the axis entering the plane of the
drawing in ﬁgs. 6 and 7, is used. This is a smoother, bell-shaped function that results
from the convolution of the intrinsic reﬂectivity curves of analyser and monochromator
Fig. 7. – Image formation principle in analyser-based imaging.
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Fig. 8. – Imaging on the 50% slope of the rocking curve.
crystals, plus the contribution from the beam divergence [34]. At a ﬁxed monochromatic
energy, as is to a good approximation the case here, thanks to the monochromator
crystal upstream of the sample, this curve determines the probability with which X-rays
are redirected towards the detector by the analyser crystal. In the situation represented
in ﬁg. 7, the analyser crystal is positioned at the top of the reﬂectivity for the primary
beam, i.e. at the Bragg angle. The sample causes X-rays to refract, on the basis of the
expression given in eq. (9) —angles are highly exaggerated in ﬁg. 7 for simplicity’s sake.
If, for example, one inserts a homogeneous sphere, or a cylindrical ﬁbre with its axis
orthogonal to the plane of the drawing, this acts like a diverging lens in the X-ray regime
(due to the real part of the refractive index being smaller than unity, see eqs. (4) and (7)),
with X-rays hitting the edges of the sample being refracted at the highest angles, as there
the gradient of the phase change is maximum. If the refraction angle is larger than half
the full width at half-maximum (FWHM) of the rocking curve, then these deviated X-
rays have a small probability of being re-directed by the crystal towards the detector.
Areas of diminished intensity, as represented in the intensity plot at the top of ﬁg. 7, are
therefore created in correspondence to these sample positions: e.g., if the sample were
a ﬁbre entering the plane of the drawing, these would be visible as fringes of reduced
intensity running along both edges of the ﬁbre. Image contrast is thus being created that
originates from refraction, i.e. that depends on δ and not on β.
The system’s sensitivity to this type of contrast can be enhanced by using a diﬀerent
orientation of the crystal, e.g. by rocking it oﬀ its Bragg position by half the FWHM
of the rocking curve. This corresponds to 50% reﬂectivity for primary, unrefracted X-
rays, and has the signiﬁcant advantage that we are now in the position where the slope
of the rocking curve assumes maximum steepness. This means that a small change in
the direction with which the X-ray hits the crystal surface (i.e. eﬀectively the refraction
angle) translates into a large diﬀerence in the crystal reﬂectivity, i.e. in the chance that
X-ray has to be or not be re-directed towards the detector.
A graphical representation is given in ﬁg. 8, where the change in X-ray direction
is schematized on the left-hand side, and the corresponding image of a ﬁbre entering
the plane of the drawing is shown on the right-hand side. Photons traversing the sample
roughly at the centre suﬀer very little or no deviation. Consequently, they are re-directed
towards the detector with 50% eﬃciency, just like X-rays not hitting the sample at all. In
fact, the grey level inside and outside the sample shown in ﬁg. 8 is the same: a “phase”
object, i.e. an object presenting negligible X-ray absorption, was deliberately chosen in
this case, and refraction is thus to a good approximation the only source of contrast.
However, the situation is very diﬀerent for X-rays hitting opposite edges of the sample.
These are refracted in opposite directions: hence, those hitting one edge are sent towards
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the top of the rocking curve (in this case, the ones deviated upwards, i.e. those hitting
the top edge of the sample). This corresponds to a much higher reﬂection probability:
more photons are therefore redirected towards the detector, and a positive (bright) fringe
is created. The opposite occurs for X-rays refracted in the opposite direction, i.e. in this
case downwards: these will be sent towards a region of the rocking curve with very low
reﬂectivity, much lower than the 50% reﬂectivity of unrefracted photons —therefore a
negative (dark) fringe will be created. It should be noted that, by changing the direction
along which the crystal is rocked oﬀ the Bragg position, positive and negative fringes
are inverted: this corresponds to switching the phase contrast signal, while absorption,
if present, would remain the same. In fact, a few years after the method was introduced,
this eﬀect was exploited by Chapman and co-workers to develop one of the ﬁrst methods
to separate phase and absorption (“phase retrieval”), by taking two images on opposite
slopes of the rocking curve and alternately eliminating phase and absorption components
through an opportunely weighted sum/subtraction [35]. Chapman called this approach
“Diﬀraction Enhanced Imaging” (DEI), and the name became so popular that for a few
years it was used interchangeably with ABI to indicate the imaging method itself, as well
as the phase retrieval algorithm.
The direct link between image contrast and refraction angle, and therefore its depen-
dence on the ﬁrst derivative of the phase shift (eq. (9)), makes ABI the ﬁrst “diﬀerential”
phase contrast imaging method, a characteristic it now shares with edge illumination and
grating interferometry (see below).
Generally speaking, ABI became very popular in the mid-nineties, especially thanks
to the famous 1995 Nature letter by Wilkins’ group [13], and still remains a widely used
technique to this day. It has to be said, however, that a few little known examples exist
that pre-date that deservedly famous paper, where eﬀectively the same method had been
used to address speciﬁc scientiﬁc problems, and the results were published in journals
with relatively limited diﬀusion [36,37]. In general, it looks like most ABI-related research
pre-dating Wilkins et al.’s letter was conducted in the former Soviet Union (see, e.g., [37]),
and published in Russian journals which at the time found limited (if any) diﬀusion in
the Western World. Wilkins himself, in the patent [32] immediately preceding his Nature
letter, quotes a patent by a Russian group [38], which was published internationally in
1992, but was of course preceded by a Russian patent application. Indeed, shortly after
the publication of Wilkin’s letter and still in 1995, two of the inventors on that patent
(Ingal and Beliaevskaya) published an article in an internationally renowned journal of
applied physics, which went on to become another highly cited, landmark paper on the
subject [14].
Following planar implementations, CT implementations were explored ﬁrst by Dilma-
nian [39], then perfected by many others (see, e.g. [40-43]). Several parameters assume
a particular importance when ABI is combined with CT (e.g. the relative orientations
of the axis of CT rotation and the one around which the crystal is rocked); however, a
detailed discussion of CT implementations lies beyond the scope of the present review
paper, and the reader is referred to the quoted papers (and references therein) for details.
Another key development that was achieved through ABI, typically involving fur-
ther developments of Chapman’s original DEI algorithm, is “dark ﬁeld” or “ultra-small
angle scatter” imaging. Researchers started to observe that, alongside the local lateral
(i.e. angular) shift of the rocking curve due to sample-induced refraction, an additional
observable eﬀect was a local “broadening” of the curve itself. This was attributed to
multiple refraction in diﬀerent directions caused by structures in the sample too small to
be resolved by the detector pixels: in this sense, it is an indication of the “inhomogene-
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Fig. 9. – “Free-space propagation” or “in-line holography” phase contrast imaging.
ity” of the sample on the sub-pixel scale —e.g. a partially crystalline material creates a
much stronger “dark ﬁeld” signal than an amorphous and homogeneous one. Interest-
ingly, three separate groups (at Elettra in Trieste, at the ESRF and in the US) came to
the same conclusion, and formulated independent approaches which however have clear
common bases [44-46]. Interestingly, this same “broadening” is mentioned by Wilkins
in his 1995 patent [32] (but, to the best of our knowledge, not in a published paper):
he mentions this not with reference to ABI, despite it being the main subject of the
patent, but with reference to an aperture-based implementation of the Shack-Hartmann
concept which has more than one point in common with the “edge illumination” method
discussed below (sect. 2.4).
The “dark ﬁeld” approach was also translated into CT implementations by Rigon et
al. ﬁrst [47], then by Ando’s group [48] and others.
The list of medical applications explored with ABI is way too long to be discussed
thoroughly here; it includes breast imaging, interestingly since the early days of the
method [34,49] as well as in CT [50] and at very low dose [51]; cartilage [52], also in vivo
on small animals [53]; bone/implant integration [54], lung functionality [55], and much,
much more —the authors apologize for all the interesting work that is not quoted here,
but providing a full list lies outside the scope of this review.
2.3. Free-space propagation or in-line holography . – In another landmark 1995 pa-
per [11], Snigirev and co-workers demonstrated that, if a source of suﬃcient coherence is
available, phase eﬀects can be observed without the need for any optical element. This
extremely simple principle is schematized in ﬁg. 9: by placing the detector at some dis-
tance from the sample, rather than directly in contact with it as is normally done in
conventional radiology, an interference pattern is generated. If a suﬃcient propagation
distance is introduced, the portion of the wave that has traversed the sample and is, as
a consequence, distorted, will interfere with the unperturbed components of the wave
front travelling immediately outside the sample itself (which therefore plays the role of
the “reference” wave).
The phenomenon can be easily interpreted in terms of near-ﬁeld Fresnel diﬀrac-
tion [56], as already pointed out by Snigirev in his 1995 paper, and speciﬁcally by means
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Fig. 10. – Reference frame for the formulation of free-space propagation XPCi in terms of
Fresnel/Kirchhoﬀ diﬀraction integrals.
of the Fresnel/Kirchhoﬀ diﬀraction integral
E(x, y) = − i cos θ
λ
∫
dξ
∫
dψf(ξ, ψ),(10)
where E(x, y) is the electric ﬁeld at the generic point x, y of the image plane, and the
integral over ξ, ψ extends over the entire sample plane (see ﬁg. 10). θ is the inclination
factor [56], and is often assumed to be ∼ 0 if the longitudinal distances (zso, source-to-
object distance and zod, object-to-detector distance) are much larger than the transverse
dimensions of the imaged object, as is practically always the case in synchrotron radiation
experiments.
The function f is given by
f(ξ, ψ) =
exp(2πi/λ{[z2so + (x− ξ)2 + (y − ψ)2] + [z2od + (ξ − x)2 + (ψ − y)2]}√
[z2so + (x− ξ)2 + (y − ψ)2][z2od + (ξ − x)2 + (ψ − y)2]
(11)
× exp[iΦ(ζ, ψ)],
where x and y specify the source location in the source plane, and Φ is the phase shift
introduced by the object as deﬁned in eq. (6). The integral is typically solved numerically,
often using simplifying tricks (see, e.g. [11,57]), and the squared modulus of the electric
ﬁeld as expressed by eq. (10) yields the X-ray intensity on the image plane.
Apart from the (typically negligible) blurring eﬀect due to the ﬁnite computa-
tional grid adopted to solve eq. (10) numerically, this intensity will typically have the
shape depicted in ﬁg. 11(a): alongside the (extremely intense) main minima/maxima
corresponding to the physical edges of the imaged object (see also ﬁg. 9), a series of sec-
ondary minima and maxima will appear. However, this would correspond to a pattern
generated by an “ideal” point source, and acquired with a detector device with virtually
inﬁnite spatial resolution: as a consequence, such a pattern is never observed in practice,
as already pointed out since the early days of the approach [11, 58]. A simple way to
take ﬁnite source size and detector resolution into account is to use convolution inte-
grals [57, 59]: the pattern observed experimentally is obtained by convolving the “pure”
pattern (as shown in ﬁg. 11(a)) with the point spread function (PSF) of the used detector
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Fig. 11. – Eﬀect of ﬁnite source size and limited detector resolution on the free-space propagation
XPCi pattern.
and with the “re-scaled” source distribution (s′ = s · zod/zso where s is the “physical”
source distribution).
The PSF and s′ can eﬀectively be combined in a single “spread” function S = PSF∗s′
(where ∗ is the convolution operator), which eﬀectively means that they have the same
eﬀect on the acquired image [60]. In fact, examples exist where either the blurring eﬀect of
the detector [61] or of the source [62] have been partly eliminated through deconvolution
procedures, depending on which one was dominant. Panels (b), (c) and (d) in ﬁg. 11
show the eﬀect on the “pure” free-space propagation of a bell-shaped “spread” function
S with FWHM equal to 50μm, 100μm and 300μm, respectively. As can be seen, not
only are the secondary phase peaks completely eliminated, but also the intensity of the
primary peaks is severely aﬀected, to the extent that they practically disappear when
S = 300μm. This indicates the strong need for small focal spots and high detector
resolution, which will be discussed in more detail in sect. 4.
Observing the eﬀect that the convolution with S has on the “pure” free-space
propagation XPCi pattern enables an additional observation. It is in fact possible to
re-draw ﬁg. 9 based on the considerations used when ﬁg. 7 was discussed, i.e. on the
basis of eq. (9), which links the X-ray refraction angle to the gradient of the refractive
index inside the sample. As said, this is maximal along the edges of the details, therefore
leading to a situation like that (qualitatively) sketched in ﬁg. 12. As can be seen,
the eﬀect of refraction at the edges is that of subtracting photons from the region
immediately inside the object, leading to a reduction in the detected intensity i.e. a pair
of negative peaks. These photons have not been eliminated, but simply redirected to
the region immediately outside the detail, whey they add up to the undisturbed photons
that travelled straight in the vicinity of the object. This creates a local increase in the
detected intensity, i.e. a pair of positive peaks. Although the pattern calculated in this
way cannot, for obvious reasons, reproduce the secondary phase peaks, its appearance is
remarkably similar to that of e.g. the pattern shown in ﬁg. 11(b), which was obtained by
convolving the Fresnel/Kirchhoﬀ diﬀraction pattern featuring all secondary oscillations
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Fig. 12. – Ray-tracing interpretation of free-space propagation phase contrast imaging.
with a bell-shaped spread function S of appropriate width. In fact, papers like [18]
and especially [17] demonstrate that, in cases of limited coherence, i.e. when laboratory
sources, or even some synchrotron sources with limited coherence like bending magnets,
are used, the simpliﬁed ray tracing and the more rigorous wave optics model yield
indistinguishable results. Albeit there are examples in the literature that seem to suggest
a separate treatment of “refraction” and “diﬀraction” eﬀects (see, e.g. [63]), these are
ultimately the same phenomenon, described by means of models with diﬀerent degrees
of approximation. While with high degrees of coherence the simpliﬁed ray-optics model
breaks down and it is necessary to use the more rigorous wave optics approach (see,
e.g [17,64]), they can be used interchangeably in cases where coherence is suﬃciently low.
While the strict requirements on S, and therefore on s, imply that spatial coherence is
a key parameter in free-pace propagation XPCi, the lesser impact of temporal coherence
was observed since the early days of the method. In fact, Wilkins and co-workers’ second
Nature letter is based on free-space propagation images obtained with a micro-focal (to
satisfy the spatial coherence requirements), but fully polychromatic, X-ray source [12].
Interestingly, images of similar quality were obtained previously by other researchers
(see, e.g. [65]), who however did not interpret the substantially improved image quality
in terms of phase eﬀects.
Several authors studied ways to incorporate polychromaticity into image formation
models (see, e.g. [60,66]), and even used it to perform energy-based phase retrieval [67],
albeit under a set of simplifying assumptions. Indeed, since the incoherent sum of the
intensities is used in this case, polychromaticity can be included simply by means of a
weighted sum over the spectral densities [60]. Excellent examples of recipes summarizing
the eﬀect of the various system parameters on key image metrics like contrast, signal-to-
noise ratio (SNR) and resolution can be found in the work of Gureyev and collaborators
(see, e.g. [68-70]).
Before developing his “energy-based” retrieval approach [67], Gureyev has been heav-
ily involved in the development of quantitative phase approaches, practically since the
origins of the method (see, e.g. [71, 72]). Phase retrieval methods for free-space prop-
agation XPCi are many and diverse, and again listing them all would go beyond the
scope of the present review; hence, we will name just a couple of signiﬁcant examples.
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Fig. 13. – The basic principle of edge illumination phase contrast imaging.
Cloetens’ “holotomography” approach, still widely used, links retrieval and CT and re-
quires a sequence of projection images acquired at a range of zod values [73]. Paganin
and co-workers, by imposing the strong constraint that the sample should be made of a
single material, developed a retrieval approach that requires the acquisition of a single
image [74]. The great advantage of requiring a single input image, jointly with the fact
that the algorithms often yields satisfactory results also if the above condition is partly
violated, probably makes it the most widely used phase retrieval method.
Similarly diversiﬁed are extensions to CT, which date back to the origins of the method
(especially at the ESRF, see, e.g. [75-77]), with subsequent signiﬁcant contributions to
quantitative aspects provided by Bronnikov [78], Barty et al. [79], and many others. Even
more diverse is the range of pursued applications, for which we refer the reader to the
quoted reviews [8,9] as well as [80-84]. Interestingly, mammography has been one of the
ﬁrst medical applications to be pursued, in particular by the Trieste group [57,85], which
will be the subject of sect. 3.
2.4. Edge illumination. – Edge Illumination (EI) XPCi was developed at Elettra in the
late ’90, as an alternative to ABI that does not require the use of an analyser crystal [15].
The basic idea is to illuminate only one edge of the detector pixels, as schematized
in ﬁg. 13(a). Imagine that the schematized set-up extends indeﬁnitely in the direction
entering the plane of the drawing. The beam is shaped by a slit to be very thin in
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the vertical direction, and to extend suﬃciently to cover the full extent of the object
in the horizontal one. The detector consists of a single row of pixels, as large as the
beam in the horizontal direction. As often done in synchrotron experiments, 2D images
are then obtained by scanning the sample vertically through the beam, reading out an
image line at each object position, then combining these lines to form the image. The
main diﬀerence in this case is that the beam, rather than matching the detector active
surface or at least hitting it in the centre, hits the edge of the pixel array. In this way,
when no object is present (ﬁg. 13(a)), the detector counts 50% (or any given percentage,
depending on the relative shift between beam and detector) of the primary photons.
This situation is eﬀectively equivalent to positioning an analyser crystal between sample
and detector tuned at 50% reﬂectivity. When an object is introduced, any gradient in
its refractive index will cause refraction i.e. induce a beam deﬂection (for simplicity’s
sake, in the ﬁgure the object is represented as a wedge inducing a uniform refraction
angle across the beam, and the angle itself has been highly exaggerated). An upward
deﬂection (ﬁg. 11(b)) will cause a reduction in the number of detected photons, i.e. a
negative fringe in the image; conversely, a downward deﬂection will result in the detection
of more X-rays i.e. a positive fringe. For example, if a cylindrical ﬁbre (entering the plane
of the drawing) is scanned across the beam, an image analogous to that showed on the
right-hand side of ﬁg. 8 is obtained. It can also be shown that, if one adjusts the vertical
beam dimension and/or the value of zod so as to obtain the same angular selectivity
(i.e. achieve the same phase sensitivity) as a given crystal reﬂection, identical images
are eﬀectively obtained. This analogy with ABI, already pointed out in the original EI
paper [15], was recently formally demonstrated [86]. Although the method maintains
common features with free-space propagation (an equivalent interpretation is to imagine
a version of ﬁg. 12 where all X-rays that do not contribute to the signal are eliminated:
for more details see [87, 88]), it is easy to see that it fully decouples the intensity of
the signal from the spatial resolution of the detector [15]. For example, with reference
to ﬁg. 13, one could imagine extending the vertical dimension of the pixel downwards
indeﬁnitely (leading to an arbitrarily large PSF): so long as the beam keeps hitting the
top edge of the pixel, the detected signal would not change.
The synchrotron EI set-up oﬀers a number of additional options. For example, shifting
the beam further upwards with respect to ﬁg. 13(a), so that it just misses the detector
active surface, leads to a form of “single-shot” dark ﬁeld imaging [89]. Clearly one can
use detectors consisting of more than one row of pixels [90], and through the design of
appropriate masks [91], simultaneously acquire absorption, phase contrast and dark ﬁeld
images by means of a single scan of the sample through the beam [92,93].
More recently, as a result of a collaboration among three synchrotrons (Elettra, Dia-
mond and the ESRF), the method has been the subject of intense investigation, which
demonstrated a number of signiﬁcant features. First, that the method allows fully quan-
titative phase retrieval through the acquisition of only two images [94], obtained by
illuminating the opposite edges of the pixel: this eﬀectively inverts the diﬀerential phase
signal, while absorption remains the same, similarly to what happens in ABI when op-
posite sides of the crystal rocking curve are used. Secondly, it was show that the method
is highly robust against increasing X-ray energy, to the extent that it can provide image
contrast tens of times higher than other XPCi approaches as energy is increased [95].
Third, and possibly most importantly, it was proven that, if the set-up is optimized
and the phase retrieval method further developed to include coherence eﬀects [64], the
method outperforms other diﬀerential XPCi approaches in terms of phase sensitivity, by
at least one order of magnitude [64,96,97].
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Fig. 14. – Schematic representation of the lab implementation of edge illumination phase contrast
imaging (sometimes referred to as “coded-aperture” XPCi).
The other key aspect enabled by the fact that EI is eﬀectively a “crystal-less” ABI
approach is that, unlike in real ABI, divergent and polychromatic beams can be used.
This enables adaptation for use with conventional sources, which was achieved by means
of a pair of opportunely designed masks [98, 99] (sometimes called, possibly slightly im-
properly, “coded-aperture” masks). Figure 14 shows a schematic side view of the imaging
system, where once again one should imagine the set-up extending in the direction en-
tering the plane of the drawing. The two masks are identical, apart from a scaling factor
that accounts for the beam divergence. The larger one is placed in contact with the de-
tector, and its only purpose is to create insensitive regions between adjacent pixels (e.g. it
could be eliminated by using specialized detector technology, or it could be directly lam-
inated onto the detector device). The downscaled mask is placed immediately before the
imaged sample (therefore protecting it from unwanted dose delivery), and it serves the
purpose of creating an array of physically separated “beamlets”. Each beamlet hits the
transition region between a sensitive and an insensitive area on the detector array, there-
fore replicating the situation schematized in ﬁg. 13(a) for each row of an area detector.
The availability of many beams eﬀectively replaces the scanning needed at synchrotrons:
here the sample is simply placed downstream of the ﬁrst mask and imaged. If no phase
retrieval is required (see below), the method is eﬀectively single shot.
Early simulations developed before the system was realized in practice [99] predicted
a negligible decrease in the detected (diﬀerential) phase signal for focal spots of up to
at least 100μm. Given the method’s links with free-space propagation [87, 88], and
considering the high sensitivity of the latter to increasing focal spot sizes, this was under
many respects an unexpected outcome, which was however repeatedly demonstrated
experimentally [98-101]. Data analysis and critical review of the methodology led to the
conclusion that there are two reasons behind this robustness, which are:
1) The method is completely non-interferometric and purely based on the detection
of refraction, which survives under relaxed coherence conditions [17, 18, 102], al-
though it becomes more diﬃcult to detect. The shifted mask arrangement enables
its eﬃcient detection despite the lack of coherence, by signiﬁcantly reducing the
undeviated background [87].
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2) Possibly most importantly, the pitch of the apertures is relatively large. As dis-
cussed above, the disruptive eﬀect of an increasing focal spot is expressed in terms
of projected source size s′ = s · zod/zso where s is the “physical” source distribu-
tion. In our current lab set-up, zod = 0.4m and zso = 1.6m, hence a “physical”
source size of 100μm leads to a source-induced blurring of approximately 25μm.
If a pixel size of 100μm, or even close to ∼ 50μm, is used, this is smaller than
the separation between two adjacent beamlets, and so long as the beamlets remain
physically separated, the edge illumination condition can still be realized, which
means that the method still works.
This further demonstrates the very basic physical diﬀerence between the incoherent EI
method and coherent methods like for example grating interferometry (see next section).
In that case, the (equivalent of the) beamlets must overlap and interfere for the method
to work, which only happens if the phase grating is illuminated coherently. In the EI
case, the beams are deliberately kept separated so that interference is avoided (moreover,
the pre-sample mask is illuminated incoherently, which would make interference eﬀect
undetectable anyway).
One simple and eﬀective way to understand the limited impact that spatial incoher-
ence has on the EI method (for a detailed technical discussion see ref. [102]) is to represent
it as a broadening of the beamlets hitting the transition between sensitive and insensitive
regions on the detector mask. With reference to ﬁg. 14, one should imagine the vertical
proﬁles of the individual beamlets hitting the detector masks being described by the con-
volution between the projection of the apertures in the pre-sample mask with a 25μm
FWHM Gaussian (rather than simply by the (sharply shaped) former, as is depicted in
the ﬁgure for simplicity’s sake). So long as the beamlets are physically separated, also
if the projected focal spot dominates i.e. the footprint of each beamlet on the detector
mask becomes virtually Gaussian, by chopping each beamlet in half with the edge of a
detector aperture, one still remains highly sensitive to any vertical displacement of these
(blurred) beamlets.
This is also what enables the lab-based version of the phase-retrieval method to pro-
vide, within the obvious “eﬀective energy” constraints common to all methods using
polychromatic radiation [103], results in many cases indistinguishable from their syn-
chrotron counterpart [104]. Like in the synchrotron case, phase retrieval is performed by
processing two frames acquired while illuminating opposing sensitivity edges, in this case
two edges on the same detector aperture [86,104,105]. In the situation shown in ﬁg. 14,
this is obtained simply by acquiring a ﬁrst frame in the depicted conﬁguration, and a
second one after the pre-sample mask has been moved upwards by one (demagniﬁed)
detector aperture.
The interesting aspect here is that, jointly with the above discussed insensitivity
to increasing pixel size, this eﬀectively means that the EI method removes the main
limitation of free-space propagation XPCi, i.e. the rapidly decreasing signal with
increasing S = PSF ∗ s′ (see ﬁg. 11 and related discussion). In fact, increasing the pixel
size (or simply the pitch of the masks) would enable using even larger focal spot sizes,
albeit at the expense of spatial resolution. This, however, could be recovered by means
of “dithering” methods [98-100, 106], at least in those cases where exposure time is not
too stringent a requirement.
Additional advantages of the method are robustness against environmental vibra-
tions [100, 107], and, like its synchrotron counterpart, against increasing X-ray en-
ergy [101]. Reference [101], as well as [108], also shows direct examples of how EI outper-
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forms free-space propagation for the same experimental set-up, while refs. [15,95,109] do
the same for the synchrotron case. To the best of our knowledge, ref. [109] also provides
the ﬁrst example in which a diﬀerential XPCi method was made sensitive to phase eﬀects
in two orthogonal directions simultaneously, in this case by using L-shaped pre-sample
apertures instead of long slits, and aligning both sides of each L shape to two orthogonal
edges of the corresponding (square) detector apertures.
While one could be erroneously led to think that the large aperture pitch reversely
aﬀects the method’s phase sensitivity, it was recently proven that this is not the case, and
that in fact the pitch of the apertures has no inﬂuence on the sensitivity [110]. Indeed, the
same sensitivity as grating interferometry is achieved, despite the highly simpliﬁed set-up.
More recently, it was demonstrated that quantitative dark ﬁeld approaches are also
accessible by acquiring one additional image [111], i.e. three frames instead of two as
required by the “standard” phase retrieval method, and CT developments are currently
underway, with the ﬁrst examples of having appeared in recent conference proceed-
ings [96,112].
Like for previously discussed XPCi methods, providing a complete list of applications
which has been targeted by means of EI lies beyond the scope of this review, however this
is long and diverse and includes security scans [113-115], small animal imaging [116-118],
mammography [119], palaeontology [95,96], material science [120], and others.
2.5. Talbot and Talbot-Lau (or “grating”) interferometry . – The last XPCi approach
to have emerged (in the early ’2000) is Talbot (or “grating”) interferometry (see ﬁg. 15).
It exploits the phenomenon of Talbot self-imaging, on the basis of which, when a grating
is coherently illuminated, diﬀraction patterns that are an exact replica of the grating
that created them are observed at a given set of (Talbot) distances [121]. A phase
grating is often used to produce the self-images; by placing an absorption (“analyser”)
grating at one of these “Talbot” distances, any perturbation of the pattern caused by
the introduction of an object along the beam path can be sensed, and related back to
the object itself.
This is a well-known method in optics, which became available also at X-ray wave-
lengths at the end of the last millennium, thanks to the advancements in nanofabrication
techniques that enabled manufacturing gratings with a suﬃciently small pitch. Follow-
ing pioneering investigations by Cloetens et al. [122, 123], proof-of-concept results were
published in rapid succession by David et al. ﬁrst [124], and by Momose et al. shortly
afterwards [125]. The method then developed quickly, resulting, e.g., in the production
of the ﬁrst CT images [126], and experienced a sudden surge of popularity when Pfeiﬀer
et al. demonstrated that a conventional X-ray source could be used by adding a source
grating [127], i.e. switching from the Talbot to the Talbot-Lau conﬁguration [128]. As
discussed above, the phase grating needs to be illuminated coherently in order to produce
the self-images at the basis of the method itself: the source grating “slices” the extended
source in an array of mutually incoherent, but individually coherent “sourcelets”, thus
providing said coherent illumination. The lab-based implementation was also rapidly
translated to CT [129], after which another extremely popular paper was published,
again by Pfeiﬀer et al., which extends the method to dark ﬁeld imaging [130]. This was
based on an extension of the analysis carried out up to that point on “phase stepping”
curves to perform phase retrieval. A “phase stepping” curve is obtained by laterally
shifting one of the gratings with respect to the others, in (typically 8-10) sub-pitch steps,
in the direction orthogonal to the trenches (i.e. vertically with reference to ﬁg. 15). This
yields a pixel-by-pixel quasi-sinusoidal curve, the lateral shift of which is associated with
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Fig. 15. – Schematic of the Talbot-Lau interferometer. The Talbot interferometer is obtained
simply by removing the source grating: in that case, a spatially coherent source must be used.
the local change in diﬀerential phase, while the reduction in average intensity provides
absorption. Pfeiﬀer et al. observed that, as well as the shift and the intensity reduction,
a “dampening” of the oscillation is also observed, that can be linked to the dark-ﬁeld
imaging signal generated by the sample. This is equivalent to the “broadening” of the
crystal rocking curve observed 5 years before by Rigon, Pagot, Oltulu and respective
co-workers [44-46], and is in fact linked to the same physical quantity.
The popularity of the method means that it is undergoing continuous development,
including 2D grating schemes [131,132], interlaced acquisition modalities aimed at saving
acquisition time when the phase stepping procedure has to be coupled with sample
rotation in CT [133], in-depth analysis on the origins of the dark-ﬁeld signal [134] and
much more. The range of targeted applications is even more varied, and listing them
again goes beyond the scope of the present work; for details, the reader is referred to a
recent review by Pfeiﬀer et al. [135].
2.6. Other approaches. – An interesting variation on the grating method was intro-
duced in 2008 by Wen and co-workers [136]. They proposed the use of a single absorption
grating (e.g. a standard anti-scattering grid), and a Fourier-based analysis method to sep-
arate the various sample-induced signals with a single shot. The method has signiﬁcant
advantages, e.g. it enables placing the grating before the sample with consequent dose
saving, and it is easily extendable to 2D implementations [137]. Albeit the approach
comes at the price of a reduced resolution and probably sensitivity, it proved capable
to extract signiﬁcant bone structural information [138]. Wen’s following eﬀort was the
equally interesting development of an interferometer with sub-micron pitch gratings [28],
the use of which resulted in a hybrid between grating and Bonse/Hart interferometry
which, although at the moment possibly limited in terms of practical implementations,
yields great promise for increased phase sensitivity.
Huang and co-workers proposed a variation on grating interferometry where only
absorption gratings are used; these have a larger pitch than standard gratings, and the
geometrical penumbra from the ﬁrst grating is used to replace the Talbot self-image [139].
The method could be seen as a hybrid between grating interferometry and the lab imple-
mentation of edge illumination; however, it still relies on the phase stepping mechanism
to extract quantitative parameters. As such, it does not exploit the enhanced phase
sensitivity yielded by the edge illumination condition: although in some of the phase
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stepping positions this might eﬀectively be realized, the overall sensitivity is washed out
by the other positions of the phase stepping curve, at which the sensitivity is lower. A
similar approach was also proposed a few years afterwards by Choi and Park [140].
Much more could be mentioned, such as for example Pellicia and Paganin’s clever idea
to use the edge of a mirror as a sensing device [141], or Nesterets and Wilkins’ approach in
which two gratings are simultaneously scanned [142]. A number of interesting alternative
approaches have also emerged that however require very high-resolution detectors, which
could be a limitation in terms of clinical translation. Among these are for example
single-grid methods, where the refraction caused by the sample is analysed in terms of
projected grid displacements [143]; interestingly, this type of studies led to the tantalizing
observation that a simple sheet of (sand)paper can be used to replace the grid itself [144].
More examples could be quoted, which however belong primarily to the realm of early,
proof-of-concept synchrotron experiments, and are therefore slightly out of scope for a
“translational”-oriented review like this one. This notwithstanding, we ﬁnd it interesting
that the area is still extremely vital and bubbling with new ideas: these could lay the
foundations for future translational exercises, and the overall feeling is that the ﬁeld of
XPCi might still provide signiﬁcant surprises in the near future.
3. – X-ray phase contrast mammography: the world-leading experience de-
veloped in Trieste
3.1. The history of the project . – The proposal to build a Synchrotron Radiation (SR)
facility, later named Elettra, was launched during the 71st Annual National Congress
of the Italian Physical Society, in October 1985 in Trieste, Italy. Several meetings —
generally held at The Abdus Salam International Centre for Theoretical Physics (ICTP)
in Trieste— immediately focused on the issue of which beam lines had to be developed.
Preliminary conclusions were presented at a workshop in May 1987, at ICTP, where
mammography was just mentioned [145]. A new company, named Sincrotrone Trieste
SCpA (ST), devoted to the construction of the Elettra laboratory, was established in
those years.
The SYRMEP (SYnchrotron Radiation for MEdical Physics) Project, for the con-
struction of a medical beam line, already foreseeing the ﬁnal phase of “in vivo” mammo-
graphic examinations, was presented at a meeting of the Program Advisory Committee
of ST at the National Research Council (CNR) in Rome in September 1991. The project
approval was subject to the fulﬁllment of two conditions: ﬁnding the necessary funds and
starting with the “in vitro” phase, in order to verify the eﬀectiveness of the proposed
technique.
Elettra began its operations in 1993, and in the same year the construction of the
SYRMEP beam line started oﬀ. The University of Trieste (UTS) was the major source
of funding, with a signiﬁcant contribution from ST; in addition, the National Institute of
Nuclear Physics (INFN) supported the development of a new digital detection system.
The “in vitro” experimentation started in 1996 and the results of this preliminary
phase were very promising. Two years later, the international scientiﬁc committee of ST
approved the next steps of the “in vivo”, i.e. with patients, experimentation, provided
that the availability of funds was secured.
In the next year the Fondazione CRTrieste agreed to ﬁnancially support the project,
formally called “Synchrotron X-ray mammography: clinical experimentation”. Since
experiments on patients were envisaged, the UTS and the local Hospital on one side,
and the ST on the other, signed a ﬁve year agreement. The INFN continued to support
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Fig. 16. – Sketch of the imaging system for phase contrast mammography with synchrotron
radiation: (a) stationary and laminar X-ray beam, (b) movable patient support, (c) compres-
sion system, (d) holder for screen-ﬁlm cassette, (e) vertical scanning movement of the patient
and of the screen-ﬁlm system through the beam, which allows the acquisition of planar radio-
graphic images, (f) rotational movement of the patient, which allows both the craniocaudal and
mediolateral oblique views to be obtained. Reproduced, with permission, from Castelli et al.
Radiology, 259 (2011) 684 (supplementary material).
the digital detection system, also in view of possible developments in the ﬁeld of tomo-
mammographic experiments.
The beam line modiﬁcation phase started in 2000 by designing the patient room
with the micrometric precision patient scanning support, the room for radiologists and
radiographers, and the control system to comply with all the required safety regulations.
In July 2004 the Ethical Committee of the local Hospital authorized the experimentation
on patients. In the next year, an Italian ministerial agency run a dry test on the general
safety control system, leading to positive feedback; a renewed ﬁve year agreement of the
three contracting bodies deﬁned the performances to be attained and the responsibilities
of the persons involved in the experimentation. Eventually, in January 2006, the Ministry
of Health gave the ultimate approval.
A description of the original beam line can be found in [34]. The upgrade in view
of experimentation with patients on the clinical mammography system is shortly dis-
cussed in [146,147], and a sketch of the experimental setup including the patient’s bed is
shown in ﬁg. 16. This upgrade left the pre-existing experimental room for standard SR
experimental activities unaﬀected, when the patient modality is not active.
In March 2006, the ﬁrst phase of in vivo mammographic examinations at the
SYRMEP beam line commenced, using screen-ﬁlm systems as detectors. Results from
the ﬁrst nine patients were presented at the X Pisa Meeting (2006) [148]. In December
2009 the ﬁrst phase of the clinical experience with 71 patients was completed, and in June
2011 the results for the ﬁrst 49 patients (March 2006 - September 2007) were published in
Radiology [149]. Finally, in February 2013, the results of the qualitative analysis on the
complete patient cohort were presented at the Royal Society scientiﬁc meetings “Taking
X-ray phase contrast imaging into mainstream applications” [150], and the conclusive
quantitative analysis is reported in the present paper.
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3.2. Breast cancer . – Among women-speciﬁc diseases, breast cancer has become one
of the leading causes of death globally. It has been estimated that one in 12 women will
develop breast cancer at some stage in her life, owing to risk factors such as hormonal
eﬀects, age and genetic predisposition.
In Europe, breast cancer has been the most commonly diagnosed form of cancer.
Though the incidence rate has signiﬁcantly increased, there has also been an increase of
treatment and survival rates; from this point of view, the agreement among the medical
community is that early diagnosis of breast cancer has direct beneﬁcial consequences on
a successful prognosis: early detection saves lives. The ﬁrst-line approach to the early
diagnosis of breast cancer is mainly based on X-ray mammographic examinations.
Mammography, however, is far from being perfect. Its diagnostic performance may
depend on several factors, and is reported to have sensitivity between 60% and 90%, and
speciﬁcity between 80% and 95% [151, 152]. The reported positive predictive value is
usually in the order of 10% [153, 154], implying that for each true-positive patient, nine
false-positive patients are sent to further diagnostic investigations.
In Appendix A, sensitivity and speciﬁcity are deﬁned, discussing the role of the 2× 2
contingency table in the speciﬁc case of mammography, and elucidating the intrinsic
diﬃculties of this clinical diagnostic test.
The detection and characterization of breast abnormalities, including opacities, ar-
chitectural distortion and microcalciﬁcations, is in fact a most challenging task due to
their frequent small size and limited conspicuity relative to the surrounding anatomical
structures of the breast. Small or indistinct breast lesions are often visible retrospectively
when reviewing the patient’s previous examinations, but identifying them prospectively
remains diﬃcult.
The early diagnosis of breast cancer requires in particular the detection of micro-
calciﬁcations (high-contrast, small-size details) and nodules (low-contrast details). The
visibility of these details depends on object size, object contrast and X-ray intensity.
Small-size and low-contrast features require high radiation dose for a good image quality
to be achieved. However, since breast is one of the most radiosensitive organs, the risk
of radiation-induced cancer needs to be minimized. Increasing image quality without
increasing the dose is therefore one of the primary goals in mammography.
Initial X-ray mammography is often accompanied by ultrasonography (US). However,
since the number of false-positive results is high, there is a strong demand for a second-
line investigation capable of substantially reducing this number. Various methods have
been developed over the years to address these limitations in mammography, achieving
varying levels of success [155,156].
Mammography with synchrotron radiation (MSR) is an innovative X-ray imaging
technique that may be utilized to improve the identiﬁcation of breast lesions. Syn-
chrotrons provide X-ray beams which are practically monochromatic, tunable (thus en-
abling dose optimization), laminar (determining a general reduction in scattered ra-
diation) and with suﬃcient spatial coherence to allow the exploitation of phase ef-
fects [8, 9, 82, 157]. Given these conditions, XPCi can be performed at high contrast
and spatial resolution, even with reduced doses.
Previous studies have extensively discussed the improvement in image quality pro-
vided by phase contrast MSR in phantoms or surgical specimens of the breast [34,35,49,
50,57,158-161]. The results of these in vitro studies proved so encouraging that a clinical
program was launched, in what is eﬀectively the ﬁnal phase of the previously introduced
SYRMEP Project [148].
Until now, X-rays from synchrotrons have been used in digital coronary angiography
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Fig. 17. – Images of left breast in 62-year-old woman with suspicious mass identiﬁed at DM. (a)
Mediolateral oblique DM image and (c) corresponding digital zoom image show suspicious mass
(arrow) with speculated margins (BI-RADS category 4) in retroareolar region. (b) Findings on
synchrotron radiation mammographic image and (d) corresponding digital zoom image conﬁrm
and better depict the spiculated mass (BI-RADS category 5). Reproduced, with permission,
from Castelli et al. Radiology, 259 (2011) 684.
examinations conducted on 470 patients between 1979 and 2000 [162, 163]. However,
no previous studies have analyzed the diagnostic capabilities of phase contrast MSR
in a patient study. The purpose of this study was therefore to assess the diagnostic
contribution of phase contrast MSR in patients with suspicious breast abnormalities on
ﬁrst-line mammography or mammography combined with US.
3.3. Data analysis. – The study involved 71 patients with unresolved breast abnormal-
ities after conventional digital mammography (DM) and ultrasonography exams carried
out at the Radiology Department of the University Hospital of Trieste, in the years 2006-
2009. All patients were subjected to both examinations, and still the diagnosis remained
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unresolved. All details about this clinical research can been found in [149]. However,
while in that paper results form the ﬁrst 49 patients were reported, here we present the
analysis for the full cohort (69 instead of 71 patients in total, since 2 did not complete
the protocol). These cases were referred for mammography at the synchrotron radiation
facility, with images acquired using propagation-based XPCi (see above). Their average
age was 59.3 years, with a standard deviation of 9.1 years.
As a ﬁrst step to investigate the contribution of phase eﬀects to image quality, two
experienced radiologists, specialized in mammography, assessed the visibility of breast
abnormalities and of breast glandular structures, by looking at the hospital and the MRS
images of the same case side by side. Images were compared, and graded according to a
relative seven-grade visual scoring system. This led to the conclusion that phase contrast
MSR depicts normal structures and abnormal ﬁndings with higher image quality with
respect to conventional digital mammography [150]. An example of the diﬀerence in
image quality between conventional and MSR is shown in ﬁg. 17.
In a separate session, the two readers assessed all images (MSR and conventional)
independently, and rated them according to the BI-RADS categories [164]; these BI-
RADS scores were then dichotomized such that scores of 1-3 were considered to indicate
negative result and score of 4-5 were considered to indicate a positive result [149].
This scoring system enabled analyzing the data with the 2 × 2 contingency table
discussed in Appendix A. In fact the negative or positive result of the speciﬁc diagnostic
test can be compared with the ﬁnal diagnosis (negative or positive to the disease) provided
by the result of the biopsy or the follow-up at one year. Two patients did not complete
all the steps of the protocol and were thus excluded from the ﬁnal analysis; therefore the
2 × 2 tables refer to 69 patients. It should be noted that, for all patients, the delivered
radiation dose was lower or equal to the dose administered in a standard clinical DM
procedure. Full details on how the irradiation parameters were ﬁxed and how the dose
was calculated are provided in ref. [149].
3.4. Result and discussion. – Table I shows the 2 × 2 contingency table for the con-
ventional digital mammography and for the phase contrast MSR.
The results of the comparison between the two techniques are reported in table II,
Table I. – 2×2 contingency tables for hospital-based full-ﬁeld digital mammography (upper part)
and synchrotron radiation phase contrast mammography (lower part).
Digital Mammography
Ill Healthy
DM positive 23 19 42
DM negative 6 21 27
29 40 69
Phase contrast MSR
Ill Healthy
MSR positive 25 2 27
MSR negative 4 38 42
29 40 69
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Table II. – Comparison between full-ﬁeld digital mammography and synchrotron radiation phase
contrast mammography.
DM MSR
Num Den Num/Den Num Den Num/Den
Prevalence 29 69 0.42 29 69 0.42
Sensitivity 23 29 0.79 25 29 0.86
Speciﬁcity 21 40 0.53 38 40 0.95
PPV - Positive predictive value 23 42 0.55 25 27 0.93
Pearson Chi-square 7.14 46.55
Two-tailed Fisher exact probability 0.012 < 0.000001
with the various quantities (e.g. the PPV-positive predictive value) being introduced and
discussed in Appendix A.
Finally, the stratiﬁcation according to agreement/disagreement between conventional
digital mammography and for the phase contrast MSR radiation is shown in table III.
For 48 patients, 25 ill and 23 healthy, DM and MSR are in agreement; however, 3 ill
patients are negative to both tests, and 2 healthy ones are positive to both tests.
On 21 patients, 4 ill and 17 healthy, DM and MSR are in disagreement; all the 17
healthy patients are positive for DM and negative for MSR. For the 4 ill patients, 3 are
positive and 1 negative for MSR.
The disagreement on the 17 healthy patients, positive for DM and negative for MSR,
is the main diﬀerence between the two tests, with MSR providing the correct result; for
the 4 ill patients, the MSR results are also better, with more cases identiﬁed as such.
Of course, the 5 cases of disagreement between the tests and the ﬁnal diagnoses and the
4 ill patients with diﬀerent results in DM and MSR require further analysis, and show
that the method is still susceptible to improvement.
Table III. – Stratiﬁcation according to agreement/disagreement between conventional digital
mammography and phase contrast MSR.
Agreement between DM and MSR
Ill Healthy
DM and MSR positive 22 2 24
DM and MSR negative 3 21 24
25 23 48
Disagreement between DM and MSR
Ill Healthy
MSR positive 3 0 3
MSR negative 1 17 18
4 17 21
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Fig. 18. – Histogrammatic representation of the 2× 2 contingency table. The numbers reported
below the three tests provide the ﬁgures of the corresponding table. For all pair of columns i.e.
for each test, the column on the left-hand side represents the diseased patients, the one on the
right-hand side the healthy ones.
It should be noted that conventional DM is a ﬁrst-level exam. At this level, there is
great demand for a substantial improvement in sensitivity. At a second level, i.e. after
an initial mammography, the signiﬁcant number of false positives requires a targeted
strategy for their reduction, which would also lead to a corresponding reduction of cyto-
histological analyses (biopsies).
The results reported above suggest that phase contrast MSR could be used for this
aim, i.e. to clarify cases of questionable or suspicious breast abnormalities identiﬁed at
previous digital mammography exams.
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In terms of patient care implications, phase contrast MSR has the potential to be a
second-level examination after mammography, with the aim of reducing the number of
diagnostic biopsies performed.
Figure 18, actually a graphical representation of the 2× 2 contingency table, summa-
rizes all previous considerations, apart from the Pearson Chi-square or the Two-tailed
Fisher exact probability, which are computed with more complicated procedures that
refer to the respective null test (see Appendix A).
In the ﬁgure the true positives to the speciﬁc test are in dark grey, while the true
negatives are in light grey. Taking into account the ideal test, it is apparent that, in our
sample, phase contrast mammography with synchrotron radiation behaves better than
conventional digital mammography, with the largest diﬀerence being observed for healthy
patients.
4. – Beyond synchrotrons: current opportunities for clinical translation
Together with the many quoted examples where XPCi was demonstrated to out-
perform conventional X-ray methods on in vitro tissue samples, the Trieste experience
discussed in the previous chapter proves beyond doubt that XPCi can be extremely ben-
eﬁcial in real in vivo medical investigations. However, not only are synchrotrons —for
obvious reasons— not suitable for widespread clinical use; their very nature also limits
the type of in vivo studies that can be performed. In this sense, the Trieste case is
exemplary: the team only had access to patients who already underwent a conventional
examination, and for whom this did not result in a deﬁnitive diagnosis. Presented with
this patent cohort, the Trieste study successfully reduced the number of false positives
i.e. demonstrate an increased speciﬁcity. However, it could be argued that reducing the
number of false negatives would be even more important. This requires examining a
much larger population of (typically asymptomatic) patients in a screening study, which
would be much more diﬃcult to perform at a machine with a limited capacity like a
synchrotron. To make this happen, XPCi needs to be taken out of synchrotrons and
specialized labs, and into mainstream applications: the beneﬁts of this would extend
well beyond mammography as well as beyond medicine itself, and have been the subject
of a recent discussion meeting held at the Royal Society in London [165], the proceedings
of which are an immediate reference for the reader who wishes to expand on the subject.
The ﬁrst hurdle that needs to be overcome to achieve such a translation is the eﬀective
implementation of XPCi outside SR sources. This can be based on two approaches: the
development of new X-ray sources, in which higher coherence is made available without
excessively reducing the available ﬂux, or the development of XPCi methods that do not
rely on coherence, and can thus be implemented with existing X-ray sources.
4.1. New X-ray sources. – This is a wide and diverse area, with extremely exciting
possibilities been oﬀered by inverse Compton approaches [166-169], laser plasma, the use
of which was proposed already in the early days of XPCi [170], and which has more
recently demonstrated very exciting possibilities [171-173], compact synchrotrons [174],
and others; a thorough discussion of which lies beyond the scope of this review. For our
purposes, it should be noted that, also when in principle commercially available, these
sources seem not to be suﬃciently perfected yet (and in fact there is an extensive, fully
justiﬁed research activity still underway), and their current prospects in terms of cost
and dimensions are such that, for the time being, one could only envisage some sort of
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“specialized” use —e.g. large hospitals having one such source, used only for a certain
class of specialized exams.
Somewhere in between new approaches and more traditional sources is the recent
development of a liquid jet source, where the continuous “renovation” of the target ma-
terial allows overcoming the intrinsic limits associated with maximum heat loads caused
by electron beam bombardment [175]. At present, however, the technology seems to be
restricted to small focal spots, which, while possibly viable for e.g. small-animal imag-
ing [176], do not yet allow the sort of ﬂuxes required in clinical applications.
Arguably the most attractive aspect that would be oﬀered by new source technolo-
gies oﬀering both high spatial coherence and high ﬂux, is that they would enable using
the free-space propagation approach, which, as discussed in sect. 2.3, is the simplest
XPCi implementation since it does not require masks, crystals or gratings. In fact, this
simplicity has already attracted signiﬁcant interest, and has made it the subject of the
only attempt at (non-synchrotron) clinical translation of XPCi. However, its signiﬁcant
dependence on spatial coherence (see ﬁg. 11 and related discussion) meant that its use
in combination with source sizes large enough to be clinically viable led to negligible
phase eﬀects in the acquired images, ultimately resulting in “no statistically signiﬁcant
diﬀerence in recall rates and cancer detection rates when compared with conventional
ﬁlm screening” [177]. Indeed, the substantial limitations in image improvement that are
obtained when free-space propagation XPCi is used in combination with clinically viable
source sizes were known since the early days of the method [178].
4.2. XPCi with existing sources. – While there is little doubt that new source tech-
nologies will play a very important role in the future of medical imaging, a more rapid
translation would need to be based on XPCi methods which rely less on coherence, and
therefore have a chance to be implemented with existing source technologies.
While this rules out free-space propagation (for the reasons outlined above) and, for
even more obvious reasons, Bonse/Hart interferometry, it was observed that Analyzer-
based imaging can function under more relaxed spatial coherence conditions [179]. How-
ever, the introduction of a crystal automatically implies the selection of a very narrow
energy bandwidth, which again corresponds to a very ineﬃcient use of the ﬂux pro-
vided by a conventional X-ray source. In fact, while translation attempts exist [180],
these are characterized by excessively long exposure times, to the extent that the use of
multiple X-ray sources has been taken into account as a possible solution to the prob-
lem.
Still on the use of incoherent sources, enthusiasm was generated in the mid’00s by
Pfeiﬀer et al.’s demonstration that, thanks to recent developments in grating fabrication,
Talbot-Lau interferometers could be implemented at X-ray wavelengths [127]. This built
on the previous work of David et al. [124], Momose et al. [125] Weitkamp et al. [126] and
others, who demonstrated the same principle in the Talbot conﬁguration, using coherent
synchrotron X-rays. As already mentioned, the method in itself remains a coherent one:
no Talbot self-images are generated by a grating that is illuminated incoherently. What
happens in the Talbot-Lau case is that the introduction of the third, “source” grating
generates suﬃcient (spatial) coherence by collimating the extended source, along the same
lines applied to e.g. free-space propagation XPCi through the use of a multiple-pinhole
source collimator [181]. While this eﬀectively allows the use of an extended source, it
has the downside that a large fraction of the source is covered by the absorbing part
of the source grating (which typically has a less than 50% open fraction), intercepting
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the majority of the emitted ﬂux. Moreover, the necessity of creating structures thick
enough to absorb hard X-rays means that the open channels in the grating are much
longer in the X-ray propagation direction than in the transverse one, resulting in angular
ﬁltration of the emitted photons. This results in an intensity drop at the sides of the
irradiation ﬁeld, which was at least partly solved through the introduction of curved
gratings [182]. An additional factor of ﬂux loss is absorption in the silicon substrates
in which the gratings are realized. These are typically several hundred microns thick,
which has to be multiplied times three to account for the three gratings present in the
setup. Signiﬁcantly, this is in adverse relation with another limiting factor of grating
interferometry, i.e. the small available ﬁelds of view (currently limited to a maximum of
10 cm [183]). In fact, the realization of gratings of up to 10 cm in side requires the use of
at least 6-inch silicon wafers, which are typically 675μm thick [184]; while thinning is in
principle possible, it would rapidly aﬀect robustness for relatively large gratings. These
beam losses directly aﬀect exposure times, while the fact that two of the gratings are
positioned downstream of the sample aﬀects the delivered dose. Indeed, doses of tens of
Grays and exposure times of tens of hours are often encountered for CT applications [185,
186]. While planar imaging applications like mammography are less severely aﬀected by
these factors, at the time of writing the best result on mammography specimens were
obtained by Stampanoni et al. [187], in a study in which doses about 10-20 times higher
than in conventional mammography were delivered. Finally, an additional limitation is
stability. Gratings have pitches of a few microns, and the method requires phase stepping
procedures typically consisting of about 8 steps: the need for at least a 10% accuracy on
an individual phase step of a few hundred nanometers results in stability requirements
of the order of a few tens of nanometers [188], diﬃcult to realize in clinical cases; in fact,
it has been reported that, also in pre-clinical applications, scans have to be regularly
interrupted to allow for system re-alignment [185].
Laboratory-based edge illumination XPCi (in what is sometimes referred to as the
“coded aperture” approach) seems to be less aﬀected by these issues: following pre-
liminary indications that low doses might be achievable obtained during a proof-of-
concept cartilage study [116], this was more thoroughly demonstrated in a dedicated
breast study [119], in which doses were independently measured with termoluminescent
dosimeters and ionization chambers and cross-checked. More recently, it was demon-
strated that also extensions to dark ﬁeld imaging [111], breast tomosynthesis [189] and
CT [190] can be obtained at acceptable dose levels (the latter so far only for pre-clinical
applications).
This is due to the much larger pitch of the masks, which enables their fabrication on
low X-ray absorbing graphite substrates [191], and in particular to the fact that one of
the two masks is placed upstream of the sample, thus protecting it from unwanted dose
delivery. With reference to ﬁg. 14, it can be noticed that the only source of “extra” dose
with respect to a standard conﬁguration in which no optical elements are used is the
portion of each beamlet impinging on the solid septa of the detector mask. As discussed
in detail in ref. [119], this portion can be made almost arbitrarily small, hence making
the method practically 100% dose eﬃcient.
For the same reason, plus the fact that a source grating is not needed, exposure times
are also less aﬀected than in GI, and in fact some of the breast images presented in [119]
were acquired in a matter of a few seconds, which begins to be compatible with clinical
requirements, despite the suboptimal nature of the used prototype. Work is currently
underway to demonstrate that this concept can be extended to CT, and allow for example
a full 3D scan of a small animal in a few minutes.
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The use of large mask pitches has at least two additional advantages, namely scal-
ability to large ﬁelds of view (due to low aspect ratio and consequent use of less de-
manding micro-fabrication methods), and much reduced stability requirements. Indeed
most EI experiments at UCL were conducted in a room on the second ﬂoor of a popu-
lated building, which constantly “shakes” by about 2-3μm. So long as the “standard”
EI systems were used, which have a maximum resolution of about 20μm [116], these
vibrations did not seem to aﬀect image quality, and in fact images reported e.g. in pa-
pers [88,104,110,111,116,119] were obtained without any anti-vibration measure in place.
This resilience of the method to environmental vibrations was observed already when the
ﬁrst prototype was built and tested [100]. Indeed, problems due to these vibrations were
not observed until microscopic approaches were developed; however, also in that case,
simple isolation through air cushions was suﬃcient to solve the problem, and obtain a
resolution of the order of 1μm [192]. Moreover, it has been recently demonstrated that
the system can be kept dynamically aligned through a feedback mechanism [107], based
on the fact that the detector output is in itself an indication of the masks’ position.
Importantly, the larger mask pitch that enables the above advantages has no reverse
eﬀect on the phase sensitivity [110,193], and indeed the simultaneous implementation of
low-dose and high sensitivity has been recently discussed [194].
However, it is in principle possible that, since the Talbot eﬀect is not exploited, longer
sample-to-detector distances might be required by EI compared to grating approaches.
Considering also that in EI the projected source size needs to be smaller than the inter-
beamlet separation, this might lead to overall less compact setups, and is currently the
subject of investigation. On a related note, the current need to use source sizes not larger
than 100μm can make the system relatively expensive, since specialized high-powered
sources might be required; moreover, in terms of clinical translation, at the moment these
sources are only available in the area of mammography. Strategies to enable the use of
larger source sizes are therefore also under investigation.
5. – Conclusions
Research carried out in the last twenty years has demonstrated beyond doubt that
XPCi can radically transform diagnostic radiology and many other ﬁelds —practically
any area in which X-rays are used. Speciﬁcally on this aspect, it is important to notice
that the use of X-rays in science and society, although sometimes overlooked, is all-
pervasive: a partial list of areas of application would include biology, material science,
non-destructive testing, security scans, paleonthology and cultural heritage in general,
and many others.
In medicine, transition to XPCi would lead to earlier diagnosis and consequently to a
reduction of the mortality rate; as well as for diagnosis, X-ray imaging is extensively used
in treatment planning, assessment, delivery and follow-up. In the authors’ opinion, the
Trieste in vivo experience on human patients is particularly signiﬁcant, and provides the
ultimate demonstration, in case one was needed, that XPCi can indeed make a signiﬁcant
diﬀerence.
Some technological hurdles remain to be overcome to make this happen. Free-space
propagation has been particularly attractive for its simplicity: indeed, the Trieste study
is based on it, and it cannot be denied that a method not requiring any optical element
has signiﬁcant advantages. However, the current state of the art of X-ray sources does
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not seem to allow its clinical implementation: if the source size is suﬃciently small as
to produce signiﬁcant free-space propagation-induced phase enhancements, the exposure
time is too long for clinical applications; conversely, if the source is made suﬃciently large
as to allow clinically acceptable exposure times, phase-induced image beneﬁts practically
disappear. Hence, the clinical translation of free-space propagation XPCi seems to de-
pend on the development of innovative X-ray source technologies, an area bubbling with
extremely promising research ideas, but in which an ultimate solution does not seem to
have been identiﬁed yet.
This shifts the balance (at least for the time being) on methods that can work with
conventional, extended and incoherent, sources. With the caveat of an excessively large
projected source size reversely aﬀecting image resolution, grating interferometry provides
access to larger (and therefore cheaper and potentially more powerful) focal spots than
edge illumination. However, the emitted ﬂux is highly suppressed by the two absorption
gratings (one of which has an open fraction typically smaller than 50%), and by attenua-
tion in the three silicon substrates. As discussed above, this has also severe consequences
on the eﬃciency of the dose delivery. Moreover, signiﬁcant hurdles need to be overcome
in terms of mechanical stability and dimensions of the ﬁeld of view —although interesting
proposals exist to overcome the latter by means of scanning approaches [195].
Edge illumination seems to have at least partially solved the problems of excessive dose
and exposure time, and has signiﬁcantly relaxed the stability requirements; moreover,
large aperture masks can already be fabricated. However at the moment it allows the
use of source sizes up to 100μm. Sources of this size that can produce suﬃcient ﬂuxes
already exist and are used in e.g. mammography, but are typically at the high-end of
the technology and consequently quite expensive. Moreover, most system used so far are
2m long; a 1.5m system has been designed [99] and is currently under construction, and
investigations are underway to understand whether it will be possible in the future to
realize even more compact systems.
As a ﬁnal consideration, it should be noted that the ﬁnal developments needed to
translate these approaches into clinical practice fall into a sort of intermediate, “grey
area” of funding scenarios. The more “translational” aspects are not considered to be
basic science anymore, and yet, at least in the current economic climate, companies tend
to ﬁnd them too risky to undertake them in full. As a consequence, they have a tendency
to leave the “de-risking” business with the researchers, who however might struggle to ﬁnd
appropriate funding tools through the usual channels of Research Councils, etc. It would
therefore look like a more “adventurous” attitude on the companies’ side (especially the
big ones, which are active in the medical area and which could muster the appropriate
resources) could be a necessary requisite to reach the ﬁnal goal of translating the full
potential of XPCi into the clinics and beyond.
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Appendix A.
2× 2 contingency table
A 2× 2 contingency table can be used in order to evaluate a clinical diagnostic test.
It is in fact possible to verify the test eﬃciency if the presence or absence of the disease
is known in a sample of patients undergoing the diagnostic test [196,197]. The deﬁnition
of various quantities is shown in table IV.
With reference to table IV contents, the quantities listed in table V can be deﬁned.
Two interesting cases are considered in tables VI and VII, the Ideal test and (two
examples of the) the Null test, respectively. Pertinent numerical examples are discussed,
in particular with respect to the ﬁeld of mammographic tests: the sample is of a total of
10,000 patients and the prevalence is of 1%, which is a reasonable value in this area.
In the case of the Ideal test, a top-level eﬃciency is considered: the false positives
and false negatives are zero; therefore sensitivity, speciﬁcity and PPV are all equal to
100%. Hence the test can be considered “perfect”: it ﬁnds no false positives and at the
same time misses no one with the disease. The ideal situation is of course hardly ever
encountered in practice, but the Ideal test case can nevertheless be useful in discussions
on the results of the clinical experimentation (see e.g. end of sect. 3.4).
In the second case (Null test), a minimum of eﬃciency is considered; in the two cases,
the sample is divided in a diﬀerent number of test positives and test negatives, but the
percentage of ill patients is the same in the two cases and is equal to the prevalence;
i.e. the PPV is equal to the prevalence. Of course the aim of any diagnostic test is to
improve the PPV with respect to the prevalence: a mere proportionality makes the test
completely useless, which applies in the same way to both cases represented in table VII.
The two parts of table VIII enable discussing a more realistic numerical simulation.
In sect. 3.2, the diagnostic performance of mammography is reported to have sensitivity
between 60% and 90%, and speciﬁcity between 80% and 95%. If maximum values are as-
sumed for both these quantities, the Data 2×2 contingency table with the corresponding
Null test can be computed. This results in a PPV of 15.4%: out of 6.5 test positives, only
1 patient is really ill. As far as the null test is concerned, the corresponding sensitivity
would have to be equal to 5.85%, much lower than the 90% sensitivity of the data.
The next step in the veriﬁcation of the test’s eﬀectiveness consists in checking whether
Table IV. – 2× 2 contingency table.
Disease
Test
True Positive False Positive Test Positive
False Negative True Negative Test Negative
Disease Positive (ill) Disease Negative (healthy) Total
Table V. – Prevalence, sensitivity, speciﬁcity and positive predictive value (PPV) deﬁned as a
function of the contingency table’s entries.
Prevalence Ill / Total
Sensitivity True Positives / Ill
Speciﬁcity True Negatives / Healthy
Positive Predictive Value (PPV) True Positives / Test Positives
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Table VI. – 2× 2 contingency table of an Ideal test.
True positive: 100 False positive: 0 Test positive: 100
False negative: 0 True Negative: 9900 Test negative: 9900
Ill: 100 Healthy: 9900 Total: 10000
Table VII. – 2× 2 contingency tables for two examples of “Null” test.
Null test – case 1 Null test – case 2
True positive: False positive: Test positive: True positive: False positive: Test positive:
1 99 100 10 990 1000
False negative: True Negative: Test negative: False negative: True Negative: Test negative:
99 9801 9900 90 8910 9000
Ill: 100 Healthy: 9900 Total: 10000 Ill: 100 Healthy: 9900 Total: 10000
Table VIII. – 2 × 2 contingency tables for a realistic example (corresponding to prevalence =
1%, sensitivity = 90%, speciﬁcity = 95% and PPV = 15%) and relative null test.
Data: Null test:
True positive: False positive: Test positive: True positive: False positive: Test positive:
90 495 585 5.85 579.15 585
False negative: True Negative: Test negative: False negative: True Negative: Test negative:
10 9405 9415 94.15 9320.85 9415
Ill: 100 Healthy: 9900 Total: 10000 Ill: 100 Healthy: 9900 Total: 10000
the data test is compatible (within a given level of conﬁdence) with the corresponding null
test. The computation of the Pearson Chi-square [198] with the appropriate probability,
or, in particular cases, the Two-tailed Fisher exact probability, provides this type of
answer. The results of this procedure have been used for the table of “Comparison of
diagnostic performances” presented in sect. 3.4.
The total number of patients for this clinical research is 69, which allows computing
the Two-tailed Fisher exact probability. For the conventional digital mammography this
value is 0.012, while for the phase contrast mammography with synchrotron radiation it
is lower than 0.000001: this demonstrates the superiority of the second test, by taking
into account directly the compatibility with the corresponding null test.
Also without resorting to statistical calculations, it is possible to become convinced
that phase contrast mammography with synchrotron radiation performs better simply
by looking at the values of the PPV in the two cases. In fact, the PPV goes from 55%
to 93%, with a common prevalence of 42%. The PPV is a ratio: in the examined case,
the numerator is practically constant, but the denominator decreases substantially. As
has been already pointed out, while there was no increase in true positives, a substantial
decrease of false positives was observed, with a corresponding increase, in this particular
case, of true negatives.
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